Cáceres AR - Search Results

1

Increased quality of life in patients with breakthrough cancer pain after individualized therapy: the CAVIDIOM study.

Villarroel PG, Padró JG, Marquina G, Jáñez NM, González EE, Antón A, Sánchez MB, Cáceres AR, López-López R, Cornejo RE, García PB, Fabregat RM, Fernández BC, Bermudo CL, Camps C. Villarroel PG, et al. Among authors: caceres ar. Future Oncol. 2022 Nov;18(35):3913-3927. doi: 10.2217/fon-2022-0758. Epub 2022 Dec 20. Future Oncol. 2022. PMID: 36537885 Free article.

2

[Permanent visual loss resulting from bilateral occipital infarction after shunt malfunction].

Gimeno-Pita P, Moros-Peña M, Guillén-Ballard T, Cáceres A, Eiras J, López-Pisón J. Gimeno-Pita P, et al. Rev Neurol. 2001 May 1-15;32(9):835-7. Rev Neurol. 2001. PMID: 11424035 Spanish.

3

Local effect of allopregnanolone in rat ovarian steroidogenesis, follicular and corpora lutea development.

Cáceres ARR, Cardone DA, Sanhueza MLÁ, Bosch IM, Cuello-Carrión FD, Rodriguez GB, Scotti L, Parborell F, Halperin J, Laconi MR. Cáceres ARR, et al. Sci Rep. 2024 Mar 16;14(1):6402. doi: 10.1038/s41598-024-57102-1. Sci Rep. 2024. PMID: 38493224 Free PMC article.

4

Effect of peripheral neural stimulation with allopregnanolone on ovarian physiology.

Cáceres ARR, Campo Verde Arboccó F, Sanhueza MLÁ, Cardone DA, Rodriguez GB, Casais M, Vega Orozco AS, Laconi MR. Cáceres ARR, et al. J Endocrinol. 2023 Jun 21;258(1):e230026. doi: 10.1530/JOE-23-0026. Print 2023 Jul 1. J Endocrinol. 2023. PMID: 37115241

5

Superior mesenteric ganglion neural modulation of ovarian angiogenesis, apoptosis and proliferation by the neuroactive steroid allopregnanolone.

Cáceres ARR, Campo Verde Arboccó F, Cardone DA, Sanhueza MLÁ, Casais M, Vega Orozco AS, Laconi MR. Cáceres ARR, et al. J Neuroendocrinol. 2022 Feb;34(2):e13056. doi: 10.1111/jne.13056. Epub 2021 Nov 5. J Neuroendocrinol. 2022. PMID: 34739183

6

"Rapid actions of the neurosteroid allopregnanolone on ovarian and hypothalamic steroidogenesis: Central and peripheral modulation".

Cáceres ARR, Vega Orozco AS, Cabrera RJ, Laconi MR. Cáceres ARR, et al. J Neuroendocrinol. 2020 Mar;32(3):e12836. doi: 10.1111/jne.12836. Epub 2020 Feb 16. J Neuroendocrinol. 2020. PMID: 32062869

7

Allopregnanolone alters follicular and luteal dynamics during the estrous cycle.

Asensio JA, Cáceres ARR, Pelegrina LT, Sanhueza MLÁ, Scotti L, Parborell F, Laconi MR. Asensio JA, et al. Among authors: caceres arr. Reprod Biol Endocrinol. 2018 Apr 10;16(1):35. doi: 10.1186/s12958-018-0353-y. Reprod Biol Endocrinol. 2018. PMID: 29636114 Free PMC article.

8

Methylation dynamics during folliculogenesis and early embryo development in sheep.

Pelegrina LT, Cáceres ARR, Giuliani FA, Asensio JA, Parborell F, Laconi MR. Pelegrina LT, et al. Among authors: caceres arr. Reproduction. 2017 Jul;154(1):X1. doi: 10.1530/REP-16-0463e. Reproduction. 2017. PMID: 28559481 No abstract available.

9

A single dose of allopregnanolone affects the ovarian morphology and steroidogenesis.

Pelegrina LT, Cáceres AR, Giuliani FA, Asensio JA, Parborell F, Laconi MR. Pelegrina LT, et al. Among authors: caceres ar. Reproduction. 2016 Oct 24:REP-16-0463. doi: 10.1530/REP-16-0463. Online ahead of print. Reproduction. 2016. PMID: 27777323

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters